Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STERIS plc Director's Dealing 2023

May 18, 2023

30229_dirs_2023-05-18_fc824e79-17c4-4221-b056-35be187aa7df.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2023-05-16

Reporting Person: Breeden Richard C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-05-16 Ordinary Shares S 12130 $208.61 Disposed 27970 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 27242 Indirect

Footnotes

F1: Price reflects a weighted average sale price for multiple transactions ranging from $208.50 to $209.33 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,359 of these shares held by Breeden Partnership LLP.